Bioimpedance Devices Market Size, Share, Trends, Growth, Forecasts, 2032

Bioimpedance Devices Market

Bioimpedance Devices Market By Modality (wired bioimpedance devices and wireless bioimpedance devices), By Product type (multiple-frequency bioimpedance devices and single-frequency bioimpedance devices), By End-user (specialty clinics, hospitals, rehabilitation centers, and others) And By Region: - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts, 2024-2032

Category: Medical Device Report Format : PDF Report Code: ZMR-5783 Status : Upcoming
Market Size in 2023 Market Forecast in 2032 Growth Rate (in %) Base Year
USD 522.1 Million USD 1,200.26 Million CAGR at 9.59% 2023

Description

According to the report published by Zion Market Research, the global Bioimpedance Devices Market size was valued at USD 522.1 Million in 2023 and is predicted to reach USD 1,200.26 Million by the end of 2032. The market is expected to grow with a CAGR of 9.59% during the forecast period. The report analyzes the global Bioimpedance Devices Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Bioimpedance Devices Market industry.

Global Bioimpedance Devices Market SizeRequest Free Sample

Global Bioimpedance Devices Market: Overview

Bioimpedance devices or bioelectrical impedance devices use harmless electrical current instead of radiation for the assessment of body composition. These are smaller, faster, some-being handheld, and hardly require any training for their use. The bioimpedance device measures the resistance or impedance to the flow of the electric current through the body. This information is then used to estimate total body water. The bioimpedance devices are widely used in several clinical areas including gastroenterology, postoperative monitoring, chronic inflammation, sports science, and many more.

Global Bioimpedance Devices Market: Growth Factors

The rapidly increasing obesity rate, rise in lifestyle-related diseases, and the growing demand for bioimpedance devices in the medical research and healthcare sector are major factors that are primarily fueling the growth of the global bioimpedance devices market. There is a considerable rise in chronic kidney diseases across the world. With CKD, the kidneys are damaged over time and fail to clean the blood. According to the CDC, approximately 37 million people in the United States have chronic kidney diseases. Nephrology is one of the areas of huge interest as it is been observed that bioimpedance devices may help in the process of dialysis to achieve the ideal euvolemic state.

In addition to this, one of the outstanding applications of bioimpedance devices in healthcare is the assessment of body composition which is usually used to estimate hydration and nutritional status. Owing to the rise in prevalence of chronic kidney diseases and all their applications in numerous clinical areas, there is a great demand for bioimpedance devices which in turn is boosting the growth of the global market. Moreover, they are portable, safe, easy to use, and non-invasive, and thus are highly preferred by the patients thereby fostering the growth of the market. Furthermore, technological advancements and a rise in R&D investments will spur the growth of the global bioimpedance devices market during the forecast period. However, the emerging wearable technologies which enable the user to monitor the physiological parameters continuously may hinder the growth of the global bioimpedance devices market.

Bioimpedance Devices MarketRequest Free Sample

The growth of the global bioimpedance devices market is been affected by the pandemic of Covid-19. Strict lockdowns, the constraint on traveling, social distancing, and quarantines have resulted in a change in consumer behavior, and a decline in consumer spending during the pandemic. In addition to this, the preference of the healthcare sector towards the treatment of Covid-19 patients led to the delay or postponement of other medical conditions. Moreover, due to disruption in the supply chain and restriction of personnel movement, manufacturers of the bioimpedance device faced huge challenges for the launch of new products. However, the strategic planning of the key players to overcome the loss during the pandemic will lead to the initiation of the steady growth of the market.

Global Bioimpedance Devices Market: Segmentation

The global bioimpedance devices market is bifurcated based on modality, product type, end-user, and region.

The modality segment is divided into wired bioimpedance devices and wireless bioimpedance devices.

Based on the product type, the global bioimpedance devices market is split into multiple-frequency bioimpedance devices and single-frequency bioimpedance devices.

The end-user segment is categorized into specialty clinics, hospitals, rehabilitation centers, and others.

Bioimpedance Devices Market : Report Scope

Report Attributes Report Details
Report Name Bioimpedance Devices Market Research Report
Market Size in 2023 USD 522.1 Million
Market Forecast in 2032 USD 1,200.26 Million
Growth Rate CAGR of 9.59%
Number of Pages 196
Key Companies Covered Soehnle, RJL Systems Inc., ImpediMed Ltd., Omron Healthcare Inc., General Electric Company, Bodystat, Seca, Maltron International, Cerebrotech Medical Systems, and Fresenius Medical Care.
Segments Covered By Modality, By Product type, By End-user and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Bioimpedance Devices Market: Regional Analysis

North America dominates the global bioimpedance devices market. Factors contributing to the major share of the market in this region include the adoption of advanced medical technologies, growing expenditure on healthcare products, and growing awareness regarding healthy living. Europe is expected to be the second-largest market for bioimpedance devices. On the other hand, Asia Pacific is expected to be the most lucrative market, the bioimpedance devices market in this region is expected to register the highest CAGR over the forecast period. Factors that will contribute to the rapid growth of the market include growing investments in the healthcare sector, a dense population with several health issues, and growing investments by key market players for the expansion of the business.

Global Bioimpedance Devices Market: Competitive Players

The major players in the global bioimpedance devices market are:

  • Soehnle
  • RJL Systems Inc.
  • ImpediMed Ltd.
  • Omron Healthcare Inc.
  • General Electric Company
  • Bodystat
  • Seca
  • Maltron International
  • Cerebrotech Medical Systems
  • Fresenius Medical Care.

The Global Bioimpedance Devices Market is segmented as follows:

By Modality 

By Product type 

  • multiple-frequency bioimpedance devices
  • single-frequency bioimpedance devices 

By End-user 

  • specialty clinics 
  • hospitals 
  • rehabilitation centers 
  • and others 

Global Bioimpedance Devices Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

The rapidly increasing obesity rate, rise in lifestyle-related diseases, and the growing demand for bioimpedance devices in the medical research and healthcare sector are major factors that are primarily fueling the growth of the global bioimpedance devices market. Furthermore, technological advancements and a rise in R&D investments will spur the growth of the global bioimpedance devices market during the forecast period.

The major players in the global bioimpedance devices market are Soehnle, RJL Systems Inc., ImpediMed Ltd., Omron Healthcare Inc., General Electric Company, Bodystat, Seca, Maltron International, Cerebrotech Medical Systems, and Fresenius Medical Care.

North America dominates the global bioimpedance devices market. Factors contributing to the major share of the market in this region include the adoption of advanced medical technologies, growing expenditure on healthcare products, and growing awareness regarding healthy living.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed